Literature DB >> 29176029

Serum progranulin levels in relation to insulin resistance in childhood obesity.

Eman M Alissa1, Rima H Sutaih1, Hayat Z Kamfar1, Abdulmoeen E Alagha1, Zuhair M Marzouki1.   

Abstract

BACKGROUND: Progranulin is an adipokine that is involved in the inflammatory response, glucose metabolism, insulin resistance, and may therefore be involved in chronic subclinical inflammation associated with the pathogenesis of childhood obesity. We aimed to investigate the association of circulating progranulin levels with metabolic parameters in children and to assess the importance of progranulin as a biomarker for metabolic diseases.
METHODS: A total of 150 children were consecutively recruited from the Pediatric Nutrition Clinics at King Abdulaziz University Hospital in Jeddah, Saudi Arabia. Children were classified into four groups based on quartile for serum progranulin. Anthropometric variables were measured in all study subjects. Fasting blood samples were collected for measurement of blood glucose, insulin and lipid profile.
RESULTS: Children within the upper quartile for serum progranulin concentration were heavier, more insulin resistant and had higher concentrations of serum total cholesterol, triglycerides, insulin and high sensitivity C reactive protein compared to those in the lower quartile. On correlation analysis, serum progranulin concentrations were significantly related to general and central adiposity, metabolic parameters, markers of inflammation and insulin resistance. Stepwise multiple regression showed that 26.6% of the variability in serum progranulin could be explained by measures of adiposity.
CONCLUSIONS: The increased serum progranulin concentrations were closely related to measures of adiposity, metabolic parameters, inflammatory marker and insulin resistance indices, suggesting that progranulin may be an excellent biomarker for obesity in childhood.

Entities:  

Keywords:  body mass index (BMI); childhood obesity; insulin resistance; progranulin; waist circumference

Mesh:

Substances:

Year:  2017        PMID: 29176029     DOI: 10.1515/jpem-2017-0321

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  7 in total

Review 1.  Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population.

Authors:  Thomas Reinehr; Christian Ludwig Roth
Journal:  Curr Diab Rep       Date:  2018-10-18       Impact factor: 4.810

2.  Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.

Authors:  Xiaolai Zhou; Thomas Kukar; Rosa Rademakers
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Circulating PGRN Levels Are Increased but Not Associated with Insulin Sensitivity or β-Cell Function in Chinese Obese Children.

Authors:  Fengyun Wang; Ting Chen; Ling Sun; Haitao Lv; Xuan Li; Jie Shen; Linqi Chen; Zhenyu Chu; Miao Hou
Journal:  Dis Markers       Date:  2018-07-29       Impact factor: 3.434

4.  Serum Chemerin Levels Correlate With Determinants of Metabolic Syndrome in Obese Children and Adolescents.

Authors:  Hong-Jun Ba; Ling-Ling Xu; You-Zhen Qin; Hong-Shan Chen
Journal:  Clin Med Insights Pediatr       Date:  2019-06-05

Review 5.  Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases.

Authors:  Anarmaa Mendsaikhan; Ikuo Tooyama; Douglas G Walker
Journal:  Cells       Date:  2019-03-11       Impact factor: 6.600

Review 6.  Iron Metabolism in Obesity and Metabolic Syndrome.

Authors:  Álvaro González-Domínguez; Francisco M Visiedo-García; Jesús Domínguez-Riscart; Raúl González-Domínguez; Rosa M Mateos; Alfonso María Lechuga-Sancho
Journal:  Int J Mol Sci       Date:  2020-08-01       Impact factor: 5.923

7.  Glucose metabolism among obese and non-obese children of mothers with gestational diabetes.

Authors:  Jun Lu; Yuying Gu; Leishen Wang; Weiqin Li; Shuang Zhang; Huikun Liu; Junhong Leng; Jin Liu; Shuo Wang; Andrea A Baccarelli; Lifang Hou; Gang Hu
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.